NCT02148380View on ClinicalTrials.gov

Combination of Chemotherapy and Gefitinib as First-line Treatment

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions
Non-Small-Cell Lung Cancer
Interventions
DRUG

pemetrexed plus carboplatin

DRUG

gefitinib

Trial Locations (1)

200030

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Baohui Han

OTHER

NCT02148380 - Combination of Chemotherapy and Gefitinib as First-line Treatment | Biotech Hunter | Biotech Hunter